All In Biotech

Drug Trial Radar · NCT06369012

Management of Abnormal Uterine Bleeding

Randomized Trial of Mefenamic Acid Versus Tranexamic Acid in Management of Abnormal Uterine Bleeding

Last checked: Nov 20, 2026Latest source record: Sep 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 130 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

130

Actual

Start

Mar 1, 2024

Primary completion

Sep 1, 2024

Study completion Sep 30, 2024

Sponsor

Lead sponsor
EgymedicalpediaIndustry
Sponsor type
Industry
First posted
Apr 16, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
Female only, from 15 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Abnormal uterine bleeding "AUB" describes all abnormal forms of menstrual bleeding which may result from several causes including anovulation, problems related to pregnancy, infections, vaginal and cervical abnormalities, uterine pathologies including benign and malignant tumors, coagulopathies, endocrine disorders, trauma, foreign bodies, systemic diseases and iatrogenic causes. AUB may be clinically presented by menorrhagia, metrorrhagia or menometrorrhagia. It's the most common complaint for the reproductive age females and accounts for 33% of female patients referred to gynecologists

Conditions

  • Abnormal Uterine Bleeding

Interventions

  • Mefenamic acid 500 mgDrug

    To compare the effectiveness of mefenamic acid versus tranexamic acid in the management of abnormal uterine bleeding.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Bleeding ControlTime frame: 1 week

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ain Shams University Hospitals

    Cairo, Egypt

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.